SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
47 hedge funds and large institutions have $89.6M invested in scPharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
47
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$332K | |
| 2 | +$240K | |
| 3 | +$204K | |
| 4 |
VF
Virtu Financial
New York
|
+$192K |
| 5 |
Bank of New York Mellon
New York
|
+$173K |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$489K | |
| 3 | -$316K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$292K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$275K |